TARA icon

Protara Therapeutics

33 hedge funds and large institutions have $16M invested in Protara Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 5 closing their positions.

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
14
Closed
5
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$13K
Name Holding Trade Value Shares
Change
Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$5K +$5K +1,807 New
UBS Group
27
UBS Group
Switzerland
$4K +$2.19K +697 +121%
O
28
OrbiMed
New York
$2.43K
Federated Hermes
29
Federated Hermes
Pennsylvania
$1K -$121 -46 -11%
Wells Fargo
30
Wells Fargo
California
$1K +$11 +6 +1%
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$1K +$1K +352 New
APA
32
American Portfolios Advisors
New York
$293
Goldman Sachs
33
Goldman Sachs
New York
-$781K -152,847 Closed
TI
34
Trexquant Investment
Connecticut
-$83K -16,313 Closed
PCM
35
Prelude Capital Management
New York
-$66K -12,872 Closed
Barclays
36
Barclays
United Kingdom
-$13K -2,510 Closed
Bank of America
37
Bank of America
North Carolina
-$3K -745 Closed